Genocore-Biotech.com Announce Advance Long-Acting Hemophilia B Therapy into a Registrational Trial
Shenzhen, China, December 29, 2015 — /EPR NETWORK/ — Genocore Biotech (ISIN:CN1000007515), an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibody (mAbs), today [read full press release…]